Mortality trends in an ambulatory multidisciplinary heart failure unit from 2001 to 2018.
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
12 01 2021
12 01 2021
Historique:
received:
09
08
2020
accepted:
07
12
2020
entrez:
13
1
2021
pubmed:
14
1
2021
medline:
11
8
2021
Statut:
epublish
Résumé
To assess mortality trends at 1 and 3 years from 2001 to 2018 in a real-life cohort of HF outpatients from different etiologies with depressed and preserved LVEF. A total of 2368 consecutive patients with HF (mean age 66.4 ± 12.9 years, 71% men, 15.4% with preserved LVEF) admitted to a HF clinic from August 2001 to September 2018 were included in the study. Patients were divided into five quintiles (Q) according to the period of admission. Trends for all-cause and cardiovascular mortality from Q1 to Q5 were assessed by linear regression. Patients with LVEF < 50% had a progressive decrease in the rates of all-cause and cardiovascular death at 1 year (12.1% in Q1 to 6.5% in Q5, p = 0.003; and 8.4% in Q1 to 3.8% in Q5, p = 0.007, respectively) and 3 years (30.5% in Q1 to 17.0% in Q5, p = 0.003; and 23.9% in Q1 to 9.8% in Q5, p = 0.003, respectively). These trends remained significant after adjusting for clinical characteristics and risk. No significant trend in mortality was observed in patients with LVEF ≥ 50%. In a cohort of real-life ambulatory patients with HF, mortality progressively declined in patients with LVEF < 50%, but the same trend was not observed in patients with preserved LVEF.
Identifiants
pubmed: 33436787
doi: 10.1038/s41598-020-79926-3
pii: 10.1038/s41598-020-79926-3
pmc: PMC7804393
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
732Références
Circulation. 2004 Oct 26;110(17):2618-26
pubmed: 15492298
Heart. 2018 Mar;104(5):407-415
pubmed: 28780577
Eur J Gen Pract. 2010 Dec;16(4):205-14
pubmed: 21073267
Eur Heart J. 2016 Jul 14;37(27):2129-2200
pubmed: 27206819
N Engl J Med. 1999 Sep 2;341(10):709-17
pubmed: 10471456
N Engl J Med. 2019 Oct 24;381(17):1609-1620
pubmed: 31475794
N Engl J Med. 2005 Jan 20;352(3):225-37
pubmed: 15659722
N Engl J Med. 2011 Jan 6;364(1):11-21
pubmed: 21073363
ESC Heart Fail. 2020 Feb;7(1):194-212
pubmed: 31978280
J Am Coll Cardiol. 2012 May 8;59(19):1709-15
pubmed: 22554602
N Engl J Med. 2014 Sep 11;371(11):993-1004
pubmed: 25176015
Circulation. 2016 Jul 5;134(1):73-90
pubmed: 27358439
N Engl J Med. 1991 Aug 1;325(5):293-302
pubmed: 2057034
Eur J Heart Fail. 2020 Jun;22(6):1032-1042
pubmed: 32293090
Eur J Heart Fail. 2016 Apr;18(4):402-10
pubmed: 26754527
Circ Heart Fail. 2018 Jun;11(6):e004646
pubmed: 29793934
Circulation. 2015 Jan 20;131(3):269-79
pubmed: 25398313
J Am Coll Cardiol. 2017 Nov 14;70(20):2476-2486
pubmed: 29141781
N Engl J Med. 2001 May 31;344(22):1651-8
pubmed: 11386263
J Am Coll Cardiol. 2018 Aug 7;72(6):591-601
pubmed: 30071987
JACC Heart Fail. 2018 Aug;6(8):619-632
pubmed: 30071950
N Engl J Med. 2005 Apr 14;352(15):1539-49
pubmed: 15753115
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829
Curr Heart Fail Rep. 2013 Dec;10(4):373-9
pubmed: 23943315
JACC Heart Fail. 2019 Jan;7(1):13-21
pubmed: 30606482
J Am Coll Cardiol. 2018 Jul 24;72(4):351-366
pubmed: 30025570
Lancet. 1999 Jan 2;353(9146):9-13
pubmed: 10023943
Curr Heart Fail Rep. 2017 Apr;14(2):59-70
pubmed: 28247180
JACC Heart Fail. 2018 Aug;6(8):678-685
pubmed: 30007560